Spyre Therapeutics
Price & Volume
Stats
See moreOpen | $100.35 |
Previous Close | $99.75 |
Day Range | $98.37-$100.61 |
52W Range | $21.14-$110.17 |
Market Cap | $9.3B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$215.7M |
Diluted EPS | -$1.93 |
News
See moreYahoo Finance • 10 days ago
Spyre's Ulcerative Colitis Combo Approach Gains Support From AbbVie Data, UBS Says
Yahoo Finance • 29 days ago
Exxon Mobil downgraded, BP upgraded: Wall Street's top analyst calls
Yahoo Finance • last month
Psoriatic Arthritis Market Landscape: 6 Key Late-Stage Drugs Set to Drive Future Growth | DelveInsight
Yahoo Finance • last month
Spyre (SYRE) Clears Monotherapy Phase for IBD Portfolio, Setting Up Combination Tests
About
CEO | Dr. Cameron Turtle DPHIL, Ph.D. |
Address | Building 23, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 125 |